| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Industries | HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Life Science • Pharmaceutical (& Medicine) • Diagnostics |
| Stages | Series A, Series B |
| Investing | United States |
| Investment Range | $5,000,000 - $10,000,000 |
Pontiva Healthcare Partners is a $175M life sciences venture and growth fund investing in clinical- and commercial-stage companies across therapeutics, medtech, diagnostics, and tools, with a focus on precision medicine for defined patient populations.
Pontiva Healthcare Partners is a $175M life sciences venture and growth fund investing in clinical- and commercial-stage companies across therapeutics, medtech, diagnostics, and tools, with a focus on precision medicine for defined patient populations.
What we look for: We invest in late-stage venture and growth life sciences companies at the intersection of precision medicine and defined patient populations. We focus on clinical- and commercial-stage therapeutics, medtech, diagnostics, and tools, leveraging population stratification—including gender, genetic, and demographic differences—to identify differentiated opportunities and drive strong clinical and commercial outcomes.
How we help: Active, hands-on partner to management teams across clinical, regulatory, and commercial strategy. We leverage deep clinical expertise and a broad network of KOLs, executives, and investors to refine trial design, accelerate commercialization, support follow-on financings, and position companies for strategic exits at key inflection points.
